<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03964610</url>
  </required_header>
  <id_info>
    <org_study_id>RHE_2019_10</org_study_id>
    <nct_id>NCT03964610</nct_id>
  </id_info>
  <brief_title>Multimodal Retinal Imaging of Cerebrovascular Stroke</brief_title>
  <acronym>OCTAV</acronym>
  <official_title>Multimodal Retinal Imaging of Cerebrovascular Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondation Ophtalmologique Adolphe de Rothschild</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondation Ophtalmologique Adolphe de Rothschild</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The hypothesis is that in patients with stroke, abnormalities of retinal microvascularization
      shown on color fundus photography and the depletion of retinal capillary density evaluated by
      OCT-A are markers of acute impairment of microcirculation of the central nervous system and
      are correlated with lesions on brain imaging.

      Patients hospitalized for stroke MRI-confirmed, will be included. An ophthalmologic
      assessment including color fundus photography (CFP) and OCT-A will be carried out after
      stabilization and at 3 months follow-up. Outcomes assessor will be blinded.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 15, 2019</start_date>
  <completion_date type="Anticipated">February 15, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 15, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Presence of an anomaly in color fundus photography or an anomaly of retinal capillary density to OCT-A</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Stroke</condition>
  <condition>Cerebrovascular Accidents</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>color fundus photography (CFP) and OCT-A</intervention_name>
    <description>Included patients will have an ophthalmologic assessment (OCT-A and CPF) after stabilization and at 3 months follow-up.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Acute patients with a stroke will be included
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Acute ischemic stroke

          -  With cerebral microangiopathy (defined by a SVD score &gt; 1)

        Exclusion criteria:

          -  Acute hemorrhagic stroke

          -  Anophthalmia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Rabih Hage</last_name>
    <phone>+33148036568</phone>
    <email>rhage@for.paris</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Am√©lie Yavchitz</last_name>
    <phone>+33148036454</phone>
    <email>ayavchitz@for.paris</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Fondation A de Rothschild</name>
      <address>
        <city>Paris</city>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rabih HAGE, MD</last_name>
      <email>rhage@for.paris</email>
    </contact>
    <contact_backup>
      <last_name>Nicolas VIDALIE</last_name>
      <email>nvidalie@for.paris</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>May 24, 2019</study_first_submitted>
  <study_first_submitted_qc>May 24, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 28, 2019</study_first_posted>
  <last_update_submitted>February 24, 2020</last_update_submitted>
  <last_update_submitted_qc>February 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>optical coherence tomography (OCT-A)</keyword>
  <keyword>color fundus photography (CFP)</keyword>
  <keyword>Retinal microvascularization</keyword>
  <keyword>Cerebral microangiopathy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

